Sandipto Sarkar

571 total citations
18 papers, 394 citations indexed

About

Sandipto Sarkar is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Sandipto Sarkar has authored 18 papers receiving a total of 394 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 7 papers in Immunology and 6 papers in Oncology. Recurrent topics in Sandipto Sarkar's work include Connective Tissue Growth Factor Research (11 papers), Biomarkers in Disease Mechanisms (7 papers) and Hedgehog Signaling Pathway Studies (3 papers). Sandipto Sarkar is often cited by papers focused on Connective Tissue Growth Factor Research (11 papers), Biomarkers in Disease Mechanisms (7 papers) and Hedgehog Signaling Pathway Studies (3 papers). Sandipto Sarkar collaborates with scholars based in United States, India and Jamaica. Sandipto Sarkar's co-authors include Sushanta K. Banerjee, Snigdha Banerjee, Gargi Maity, Inamul Haque, Arnab Ghosh, Amlan Das, Kakali Dhar, Archana De, Suman Kambhampati and Ossama Tawfik and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Sandipto Sarkar

18 papers receiving 393 citations

Peers

Sandipto Sarkar
Tanner J. Freeman United States
Jinglue Song China
Emira Bousoik United States
Bing Yu China
Lechuang Chen China
Qi Fang China
Shi Xu China
Christine Pich-Bavastro Switzerland
Marta Irigoyen Spain
Dimitris C. Kanellis Denmark
Tanner J. Freeman United States
Sandipto Sarkar
Citations per year, relative to Sandipto Sarkar Sandipto Sarkar (= 1×) peers Tanner J. Freeman

Countries citing papers authored by Sandipto Sarkar

Since Specialization
Citations

This map shows the geographic impact of Sandipto Sarkar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sandipto Sarkar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sandipto Sarkar more than expected).

Fields of papers citing papers by Sandipto Sarkar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sandipto Sarkar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sandipto Sarkar. The network helps show where Sandipto Sarkar may publish in the future.

Co-authorship network of co-authors of Sandipto Sarkar

This figure shows the co-authorship network connecting the top 25 collaborators of Sandipto Sarkar. A scholar is included among the top collaborators of Sandipto Sarkar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sandipto Sarkar. Sandipto Sarkar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Shah, Manish A., Jennifer R. Eads, Sandipto Sarkar, et al.. (2023). Phase II study of telomelysin (OBP-301) in combination with pembrolizumab in gastroesophageal (GEA) adenocarcinoma.. Journal of Clinical Oncology. 41(16_suppl). 4052–4052. 3 indexed citations
2.
Shah, Manish A., Khaldoun Almhanna, Syma Iqbal, et al.. (2021). Multicenter, randomized phase II study of neoadjuvant pembrolizumab plus chemotherapy and chemoradiotherapy in esophageal adenocarcinoma (EAC).. Journal of Clinical Oncology. 39(15_suppl). 4005–4005. 17 indexed citations
3.
Maity, Gargi, Arnab Ghosh, Inamul Haque, et al.. (2019). CYR61/CCN1 Regulates dCK and CTGF and Causes Gemcitabine-resistant Phenotype in Pancreatic Ductal Adenocarcinoma. Molecular Cancer Therapeutics. 18(4). 788–800. 30 indexed citations
4.
Khan, Uqba, Eric A. Hoffman, Chao Zhang, et al.. (2019). Impact of antibiotic use on response to treatment with immune checkpoint inhibitors.. Journal of Clinical Oncology. 37(4_suppl). 143–143. 11 indexed citations
5.
6.
Ghosh, Arnab, Sandipto Sarkar, Snigdha Banerjee, et al.. (2018). MIND model for triple-negative breast cancer in syngeneic mice for quick and sequential progression analysis of lung metastasis. PLoS ONE. 13(5). e0198143–e0198143. 23 indexed citations
7.
Haque, Inamul, Arnab Ghosh, Snigdha Banerjee, et al.. (2018). Leptin-induced ER-α-positive breast cancer cell viability and migration is mediated by suppressing CCN5-signaling via activating JAK/AKT/STAT-pathway. BMC Cancer. 18(1). 99–99. 45 indexed citations
8.
Maity, Gargi, Inamul Haque, Arnab Ghosh, et al.. (2018). The MAZ transcription factor is a downstream target of the oncoprotein Cyr61/CCN1 and promotes pancreatic cancer cell invasion via CRAF–ERK signaling. Journal of Biological Chemistry. 293(12). 4334–4349. 36 indexed citations
9.
Sarkar, Sandipto, Arnab Ghosh, Snigdha Banerjee, et al.. (2017). CCN5/WISP-2 restores ER-∝ in normal and neoplastic breast cells and sensitizes triple negative breast cancer cells to tamoxifen. Oncogenesis. 6(5). e340–e340. 20 indexed citations
10.
Das, Amlan, Kakali Dhar, Gargi Maity, et al.. (2017). Deficiency of CCN5/WISP-2-Driven Program in breast cancer Promotes Cancer Epithelial cells to mesenchymal stem cells and Breast Cancer growth. Scientific Reports. 7(1). 1220–1220. 22 indexed citations
11.
Sarkar, Sandipto, Arnab Ghosh, Gargi Maity, Snigdha Banerjee, & Sushanta K. Banerjee. (2017). Abstract 5891: DCIS to invasive progression in breast cancer is delayed by restoring CCN5. Cancer Research. 77(13_Supplement). 5891–5891. 1 indexed citations
12.
Subramanian, Arvind, Sandipto Sarkar, Gargi Maity, et al.. (2016). Exosomes in carcinogenesis: molecular palkis carry signals for the regulation of cancer progression and metastasis. Journal of Cell Communication and Signaling. 10(3). 241–249. 19 indexed citations
13.
Banerjee, Sushanta K., Gargi Maity, Inamul Haque, et al.. (2016). Human pancreatic cancer progression: an anarchy among CCN-siblings. Journal of Cell Communication and Signaling. 10(3). 207–216. 15 indexed citations
14.
Maity, Gargi, Archana De, Amlan Das, et al.. (2015). Aspirin blocks growth of breast tumor cells and tumor-initiating cells and induces reprogramming factors of mesenchymal to epithelial transition. Laboratory Investigation. 95(7). 702–717. 62 indexed citations
15.
16.
Maity, Gargi, Smita Mehta, Inamul Haque, et al.. (2014). Pancreatic Tumor Cell Secreted CCN1/Cyr61 Promotes Endothelial cell migration and Aberrant Neovascularization. Scientific Reports. 4(1). 4995–4995. 35 indexed citations
17.
Maity, Gargi, Sandipto Sarkar, Kakali Dhar, et al.. (2014). Abstract 2330: Transcription factor MAZ promotes cell growth and aggressive behavior of human pancreatic cancer cells. Cancer Research. 74(19_Supplement). 2330–2330. 1 indexed citations
18.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tanner J. Freeman Breakdown of academic impact, for papers by Jinglue Song Breakdown of academic impact, for papers by Emira Bousoik Breakdown of academic impact, for papers by Bing Yu Breakdown of academic impact, for papers by Lechuang Chen Breakdown of academic impact, for papers by Qi Fang Breakdown of academic impact, for papers by Shi Xu Breakdown of academic impact, for papers by Christine Pich-Bavastro Breakdown of academic impact, for papers by Marta Irigoyen Breakdown of academic impact, for papers by Dimitris C. Kanellis
Rankless by CCL
2026